| Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura (NCT00019825) | National Cancer Institute (NCI) | 1999-10-01 |
| Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus (NCT00003864) | Eastern Cooperative Oncology Group | 1999-09-03 |
| Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus (NCT00008047) | GERCOR - Multidisciplinary Oncology Cooperative Group | 1999-08-01 |
| Esophageal Cancer Risk Registry (NCT00260585) | University of Pittsburgh | 1999-06-01 |
| Nutrition Intervention Trials in Linxian Follow-up Study (NCT00342654) | National Cancer Institute (NCI) | 1999-05-20 |
| Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life (NCT00260559) | University of Pittsburgh | 1999-05-01 |
| Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas (NCT00019513) | National Institutes of Health Clinical Center (CC) | 1998-08-01 |
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer (NCT00004236) | University of Leicester | 1998-08-01 |
| Irinotecan in Treating Patients With Esophageal or Stomach Cancer (NCT00003748) | Jonsson Comprehensive Cancer Center | 1998-08-01 |
| Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781] (NCT00003381) | Alliance for Clinical Trials in Oncology | 1998-07-01 |
| Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach (NCT00003237) | Eastern Cooperative Oncology Group | 1998-06-22 |
| LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors (NCT00019435) | National Cancer Institute (NCI) | 1998-05-01 |
| Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer (NCT00003427) | Memorial Sloan Kettering Cancer Center | 1998-04-01 |
| Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus (NCT00003192) | University of Chicago | 1998-03-01 |
| Environmental and Biological Monitoring Pilot Study for Polycyclic Aromatic Hydrocarbons in Linxian, China (NCT00342472) | National Cancer Institute (NCI) | 1998-02-12 |
| Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus (NCT00003321) | European Organisation for Research and Treatment of Cancer - EORTC | 1998-02-01 |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors (NCT00003125) | Georgetown University | 1998-01-01 |
| Irinotecan in Treating Patients With Advanced Cancer of the Stomach (NCT00003137) | Alliance for Clinical Trials in Oncology | 1997-12-01 |
| Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma (NCT00230451) | University of Michigan Rogel Cancer Center | 1997-11-01 |
| Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus (NCT00003118) | Alliance for Clinical Trials in Oncology | 1997-10-01 |
| Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus (NCT00003326) | Theradex | 1997-09-01 |
| Chemotherapy in Treating Patients With Solid Tumors (NCT00003103) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |
| Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus (NCT00003087) | Memorial Sloan Kettering Cancer Center | 1997-08-01 |
| Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer (NCT00003055) | Memorial Sloan Kettering Cancer Center | 1997-06-01 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus (NCT00002984) | UNC Lineberger Comprehensive Cancer Center | 1997-03-01 |
| Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors (NCT00060268) | Roswell Park Cancer Institute | 1997-01-01 |
| PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery (NCT00002930) | Memorial Sloan Kettering Cancer Center | 1996-12-01 |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus (NCT00002883) | UNICANCER | 1996-10-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer (NCT00002951) | University of Chicago | 1996-06-01 |
| Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus (NCT00002884) | Centre Hospitalier Lyon Sud | 1996-03-01 |
| Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer (NCT00019110) | National Cancer Institute (NCI) | 1995-11-01 |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus (NCT00002711) | Memorial Sloan Kettering Cancer Center | 1995-10-01 |
| Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus (NCT00003076) | University of Michigan Rogel Cancer Center | 1995-10-01 |
| Photodynamic Therapy in Treating Patients With Early Esophageal Cancer (NCT00002935) | Roswell Park Cancer Institute | 1995-10-01 |
| Esophageal Cancer Genetics Studies (NCT00341276) | National Cancer Institute (NCI) | 1995-07-06 |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus (NCT00002631) | Radiation Therapy Oncology Group | 1995-06-01 |
| Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma (NCT00002625) | National Cancer Institute (NCI) | 1995-03-01 |
| Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer (NCT00002506) | Hoag Memorial Hospital Presbyterian | 1992-08-01 |
| Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus (NCT00002897) | European Institute of Oncology | 1992-07-01 |
| Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer (NCT00051480) | GenVec | |
| Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery (NCT00416858) | Federation Francophone de Cancerologie Digestive | |
| Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies (NCT04566393) | xCures | |
| Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes (NCT01203163) | Pinnacle Biologics Inc. | |
| Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker (NCT00318604) | Far Eastern Memorial Hospital | |